Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.98
(
1.31%
)
Bitcoin
71,289.40
(
0.07%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

microcapfun

Send PM Follow Ignore
Followers 6
Posts 560
Boards Moderated 0
Alias Born 03/13/2007

microcapfun

Re: DewDiligence post# 59379

Sunday, 02/24/2008 4:57:30 PM

Sunday, February 24, 2008 4:57:30 PM

Post# of 257257
>>Teva reported today that the CoGenesys acquisition closed (#msg-26992602), and evidently there was no valuation adjustment. I would consider this bullish for Albuferon.<<

It is clearly bullish for the hypothesis that the 'problem' with Albuferon is not a(n albumin-fusion technology) class effect. But I don't see why the acquisition closing w/o adjustment is bullish for Albuferon in particular ... given that Albuferon wasn't included in the Teva-CoGenesys deal.

micro

Life is an IQ test.

email: microcapfun@yahoo.com

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now